BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34070435)

  • 21. Establishment of iPS cell line (KLRMMEi003-A) from a patient with Usher syndrome due to USH2A mutation.
    Chen L; Wang J; Yang T; Xie L; Cui Z; Yu Q; Zhong J; Chan HF; Xue Y; Guo Y; Chen J
    Stem Cell Res; 2023 Apr; 68():103055. PubMed ID: 36863132
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Sanjurjo-Soriano C; Jimenez-Medina C; Erkilic N; Cappellino L; Lefevre A; Nagel-Wolfrum K; Wolfrum U; Van Wijk E; Roux AF; Meunier I; Kalatzis V
    HGG Adv; 2023 Oct; 4(4):100229. PubMed ID: 37654703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of a human iPSC line, INMi002-A, carrying the most prevalent USH2A variant associated with Usher syndrome type 2.
    Sanjurjo-Soriano C; Erkilic N; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V
    Stem Cell Res; 2018 Dec; 33():247-250. PubMed ID: 30468996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. USH2A Gene Mutations in Rabbits Lead to Progressive Retinal Degeneration and Hearing Loss.
    Nguyen VP; Song J; Prieskorn D; Zou J; Li Y; Dolan D; Xu J; Zhang J; Jayasundera KT; Yang J; Raphael Y; Khan N; Iannuzzi M; Bisgaier C; Chen YE; Paulus YM; Yang D
    Transl Vis Sci Technol; 2023 Feb; 12(2):26. PubMed ID: 36795064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for duplications, deletions and a common intronic mutation detects 35% of second mutations in patients with USH2A monoallelic mutations on Sanger sequencing.
    Steele-Stallard HB; Le Quesne Stabej P; Lenassi E; Luxon LM; Claustres M; Roux AF; Webster AR; Bitner-Glindzicz M
    Orphanet J Rare Dis; 2013 Aug; 8():122. PubMed ID: 23924366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of 11 novel mutations in USH2A among Japanese patients with Usher syndrome type 2.
    Nakanishi H; Ohtsubo M; Iwasaki S; Hotta Y; Mizuta K; Mineta H; Minoshima S
    Clin Genet; 2009 Oct; 76(4):383-91. PubMed ID: 19737284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.
    Ebermann I; Scholl HP; Charbel Issa P; Becirovic E; Lamprecht J; Jurklies B; Millán JM; Aller E; Mitter D; Bolz H
    Hum Genet; 2007 Apr; 121(2):203-11. PubMed ID: 17171570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2.
    Stemerdink M; García-Bohórquez B; Schellens R; Garcia-Garcia G; Van Wijk E; Millan JM
    Hum Genet; 2022 Apr; 141(3-4):737-758. PubMed ID: 34331125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
    Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
    J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II.
    Dreyer B; Brox V; Tranebjaerg L; Rosenberg T; Sadeghi AM; Möller C; Nilssen O
    Hum Mutat; 2008 Mar; 29(3):451. PubMed ID: 18273898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene.
    McLenachan S; Wong EYM; Zhang X; Leith F; Moon SY; Zhang D; Chen SC; Thompson JA; McLaren T; Lamey T; De Roach JN; Atlas MD; Dilley RJ; Chen FK
    Stem Cell Res; 2019 Apr; 36():101420. PubMed ID: 30904819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.
    Pierrache LH; Hartel BP; van Wijk E; Meester-Smoor MA; Cremers FP; de Baere E; de Zaeytijd J; van Schooneveld MJ; Cremers CW; Dagnelie G; Hoyng CB; Bergen AA; Leroy BP; Pennings RJ; van den Born LI; Klaver CC
    Ophthalmology; 2016 May; 123(5):1151-60. PubMed ID: 26927203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of a human iPSC line, INMi005-A, from a patient with non-syndromic USH2A-associated retinitis pigmentosa.
    Sanjurjo-Soriano C; Erkilic N; Vache C; Dubois G; Roux AF; Meunier I; Kalatzis V
    Stem Cell Res; 2022 Apr; 60():102738. PubMed ID: 35248879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whirlin and PDZ domain-containing 7 (PDZD7) proteins are both required to form the quaternary protein complex associated with Usher syndrome type 2.
    Chen Q; Zou J; Shen Z; Zhang W; Yang J
    J Biol Chem; 2014 Dec; 289(52):36070-88. PubMed ID: 25406310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations.
    Dulla K; Slijkerman R; van Diepen HC; Albert S; Dona M; Beumer W; Turunen JJ; Chan HL; Schulkens IA; Vorthoren L; den Besten C; Buil L; Schmidt I; Miao J; Venselaar H; Zang J; Neuhauss SCF; Peters T; Broekman S; Pennings R; Kremer H; Platenburg G; Adamson P; de Vrieze E; van Wijk E
    Mol Ther; 2021 Aug; 29(8):2441-2455. PubMed ID: 33895329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa.
    McGee TL; Seyedahmadi BJ; Sweeney MO; Dryja TP; Berson EL
    J Med Genet; 2010 Jul; 47(7):499-506. PubMed ID: 20507924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic analysis of 2299delG and C759F mutations (USH2A) in patients with visual and/or auditory impairments.
    Aller E; Nájera C; Millán JM; Oltra JS; Pérez-Garrigues H; Vilela C; Navea A; Beneyto M
    Eur J Hum Genet; 2004 May; 12(5):407-10. PubMed ID: 14970843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The usherin mutation c.2299delG leads to its mislocalization and disrupts interactions with whirlin and VLGR1.
    Tebbe L; Mwoyosvi ML; Crane R; Makia MS; Kakakhel M; Cosgrove D; Al-Ubaidi MR; Naash MI
    Nat Commun; 2023 Feb; 14(1):972. PubMed ID: 36810733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells.
    Bassuk AG; Zheng A; Li Y; Tsang SH; Mahajan VB
    Sci Rep; 2016 Jan; 6():19969. PubMed ID: 26814166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel USH2A mutations in Israeli patients with retinitis pigmentosa and Usher syndrome type 2.
    Kaiserman N; Obolensky A; Banin E; Sharon D
    Arch Ophthalmol; 2007 Feb; 125(2):219-24. PubMed ID: 17296898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.